GRPR and cancer: Moreover, when compared to non-conjugated compositions, EGCG-loaded nanoparticles conjugated with the gastrin-releasing peptide receptor (GRPR)-specific peptide bombesin demonstrated enhanced therapeutic potency and anti-migration ability in in vitro MDA-MB-231 and B16F10 cancer cell lines and in vivo female C57/BL6 mice.